rp 31264 has been researched along with cyclic gmp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, JC; Boireau, A; Dubédat, P; Farges, G; Laduron, PM; Martel, M | 1 |
| Blanchard, JC; Boireau, A; Garret, C; Julou, L; Stutzmann, JM | 1 |
2 other study(ies) available for rp 31264 and cyclic gmp
| Article | Year |
|---|---|
In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellum.
Topics: Animals; Cerebellum; Cyclic GMP; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Ligands; Male; Mice; Naphthyridines; Piperazines; Receptors, GABA-A; Sulfur Compounds; Tritium | 1988 |
Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Binding, Competitive; Cats; Cerebellum; Chlordiazepoxide; Corpus Striatum; Cyclic GMP; Diazepam; Evoked Potentials; gamma-Aminobutyric Acid; Homovanillic Acid; In Vitro Techniques; Muscimol; Naphthyridines; Nitrazepam; Phenothiazines; Piperazines; Rats; Spinal Cord; Sulfur Compounds | 1984 |